Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Kineret® (anakinra) – New indication
December 18, 2020 - The FDA approved Swedish Orphan Biovitrum’s Kineret (anakinra), for the treatment of Deficiency of Interleukin-1 Receptor Antagonist (DIRA).
